| For: | Niu ZS, Niu XJ, Wang WH, Zhao J. Latest developments in precancerous lesions of hepatocellular carcinoma. World J Gastroenterol 2016; 22(12): 3305-3314 [PMID: 27022212 DOI: 10.3748/wjg.v22.i12.3305] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i12/3305.htm |
| Number | Citing Articles |
| 1 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10) doi: 10.1002/jcb.30252
|
| 2 |
Eleni Georgakopoulou, Konstantinos Evangelou, Vassilis G. Gorgoulis. Cellular Senescence in Disease. 2022; doi: 10.1016/B978-0-12-822514-1.00001-8
|
| 3 |
Bicong Wu, Matthew M. Yeh. Hepatitis B Virus and Liver Disease. 2021; doi: 10.1007/978-981-16-3615-8_5
|
| 4 |
Monika Vyas, Xuchen Zhang. Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4) doi: 10.1016/j.cld.2020.07.010
|
| 5 |
Donglan Lu, Xue Bai, Qiyuan Zou, Zuhuan Gan, Yufeng Lv. Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co‑expression network. Oncology Letters 2020; 20(3) doi: 10.3892/ol.2020.11844
|
| 6 |
Hailun Zheng, Xiquan Ke, Dapeng Li, Qiangwu Wang, Jianchao Wang, Xiaoyang Liu, Min Deng, Xiaojing Deng, Yongju Xue, Yu Zhu, Qizhi Wang. NEDD4 promotes cell growth and motility in hepatocellular carcinoma. Cell Cycle 2018; 17(6) doi: 10.1080/15384101.2018.1440879
|
| 7 |
Jian Dong, Zhen Wang, Si-Rui Wang, Huan Zhao, Jun Li, Ting Ma. Application value of different imaging methods in the early diagnosis of small hepatocellular carcinoma: a network meta-analysis. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1510296
|
| 8 |
Ronald Miick, Corrado Minimo, Alessandro Bombonati. Hepato-Pancreato-Biliary Malignancies. 2022; doi: 10.1007/978-3-030-41683-6_3
|
| 9 |
Monika Vyas, Xuchen Zhang. Practical Liver Pathology. Practical Anatomic Pathology 2025; doi: 10.1007/978-3-031-97506-6_18
|
| 10 |
Wenqian Tang, Juan Xue, Lei Luo, Yao Wang, Xin Cai, Yuqing Liu, Dawei Huang, Xiaodong Wang, Tangqing He, Dingbo Lu, Fan Yang. Kangxianruangan granule‑containing serum mediated inhibition of hepatic oval cell differentiation into hepatocellular carcinoma cells via the Wnt‑1/β‑catenin signaling pathway. Molecular Medicine Reports 2021; 25(2) doi: 10.3892/mmr.2021.12571
|
| 11 |
Fatima Mustansir, Juan M. Sarmiento. The SAGES Manual of Contemporary Indications and Management of Hepatic and Biliary Diseases. 2025; doi: 10.1007/978-3-032-04823-3_7
|
| 12 |
Li Wang, Liuhong Pan, Min Yao, Yin Cai, Zhizhen Dong, Dengfu Yao. Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma. Oncotarget 2106; 7(27) doi: 10.18632/oncotarget.9892
|
| 13 |
Yao Yang, Chenxi Liu, Linyu Qi, Tong Zhao, Yuemin Feng, Xin Ai, Xinya Zhao, Jie Li, Qiang Zhu. Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review. Digestive Diseases and Sciences 2020; 65(9) doi: 10.1007/s10620-019-05981-0
|
| 14 |
Ronald Miick, Corrado Minimo, Alessandro Bombonati. Hepato-Pancreato-Biliary Malignancies. 2021; doi: 10.1007/978-3-030-37482-2_3-1
|
| 15 |
Onofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, William Robert Bradley, Mattia Fonderico, M. Lisa Zhang, Amirkasra Mojtahed, Mark A. Anderson, Alexander Herold, Azadeh Hajati, Valeria Pena-Trujillo, Peter D. Caravan, Samantha G. Harrington, Shadi Abdar Esfahani, Umar Mahmood, Nahel Elias, Elizabeth P. Walsh, Daniel S. Pratt, Abigail B. Scherrer, Haley Ellis, Emily D. Bethea, Claude Sirlin, Avinash Ramesh Kambadakone, David Ryan, Kelsey Lau-Min. Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with Cirrhosis. Journal of Nuclear Medicine 2026; 67(4) doi: 10.2967/jnumed.125.271228
|
| 16 |
Qiang Liu, Jie Bian, Hongjun Li. Consensus on imaging techniques and diagnostic criteria for hepatitis B virus-related early hepatocellular carcinoma. Radiology of Infectious Diseases 2023; 10(2) doi: 10.4103/RID.RID_5_23
|
| 17 |
Mukul Vij, Julien Calderaro. Pathologic and molecular features of hepatocellular carcinoma: An update. World Journal of Hepatology 2021; 13(4): 393-410 doi: 10.4254/wjh.v13.i4.393
|
| 18 |
Shahrzad Yazdanpanah, Bita Geramizadeh, Saman Nikeghbalian, Seyed Ali Malek-Hosseini. Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran. Hepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.38584
|
| 19 |
Sijie Cheng, Tieling Li, Cheng Wang, Keyu Wang, Chengcai Lai, Jin Yan, Hongxia Fan, Fang Sun, Zhaohai Wang, Peirui Zhang, Linxiang Yu, Zhixian Hong, Guanglin Lei, Baijun Sun, Yuan Gao, Zhaohui Xiao, Xu Ji, Ruilan Wang, Jianzhong Wu, Xiliang Wang, Shaogeng Zhang, Penghui Yang. Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma. Oncotarget 2018; 9(90) doi: 10.18632/oncotarget.23282
|
| 20 |
Alexandra M. Adams, Ahmed O. Kaseb, Hop S. Tran Cao. Transplant Oncology. 2025; doi: 10.1016/B978-0-443-21901-6.00003-3
|
| 21 |
Tian-Yang Chen, Jing-Yin Mai, Ping Zhang, Jian-Hua Xue, Sheng-Li He, Jun Xi, Jian-Jie Chen, Yang Cheng. Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia. Medicine 2021; 100(38) doi: 10.1097/MD.0000000000027231
|
| 22 |
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022; 12(5) doi: 10.3390/bios12050342
|
| 23 |
Kwun Wah Wen, Sanjay Kakar. Hepatic Precancerous Lesions and Early Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2024; 53(1) doi: 10.1016/j.gtc.2023.11.005
|
| 24 |
Shuang Yang, Yongqiu Li, Christopher W Wheldon, Jessica Y Islam, Mattia Prosperi, Thomas J George, Elizabeth A Shenkman, Fei Wang, Jiang Bian, Yi Guo. The Burden of Cancer and Precancerous Conditions Among Transgender Individuals in a Large Health Care Network: Retrospective Cohort Study. JMIR Cancer 2025; 11 doi: 10.2196/73843
|
| 25 |
Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuanyong Guo. <p>Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma</p>. Journal of Hepatocellular Carcinoma 2020; doi: 10.2147/JHC.S277870
|
| 26 |
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; doi: 10.1016/B978-0-323-40232-3.00132-1
|
| 27 |
Justine Boutry, Sophie Tissot, Beata Ujvari, Jean-Pascal Capp, Mathieu Giraudeau, Aurora M. Nedelcu, Frédéric Thomas. The evolution and ecology of benign tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1) doi: 10.1016/j.bbcan.2021.188643
|
| 28 |
Elvire Desjonqueres, Claudia Campani, Fabio Marra, Jessica Zucman‐Rossi, Jean‐Charles Nault. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Liver International 2022; 42(3) doi: 10.1111/liv.15152
|
| 29 |
Monika Vyas, Dhanpat Jain. A practical diagnostic approach to hepatic masses. Indian Journal of Pathology and Microbiology 2018; 61(1) doi: 10.4103/IJPM.IJPM_578_17
|
| 30 |
Zhun Xiao, Fangming Yang, Zheng Liu, Xinju Chen, Suping Ma, Heng Li. An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241293019
|
| 31 |
. 2019; doi: 10.70675/f7065ff4z394fz4ce2za236z344b5244c7dc
|
| 32 |
Juliane Lokau, Victor Schoeder, Johannes Haybaeck, Christoph Garbers. Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma. Cancers 2019; 11(11) doi: 10.3390/cancers11111704
|
| 33 |
|
| 34 |
Lina Lu, Zhonglin Jiang, Yulin Dai, Luonan Chen. Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers. Genes 2017; 8(10) doi: 10.3390/genes8100268
|
| 35 |
Nicholas D. Priest. A Nontarget Mechanism to Explain Carcinogenesis Following α-Irradiation. Dose-Response 2019; 17(4) doi: 10.1177/1559325819893195
|
| 36 |
. 2022; doi: 10.70675/fa80c98bz7ab1z4e7ezb176z1a7e1602e53e
|
| 37 |
Riccardo Inchingolo, Riccardo Faletti, Luigi Grazioli, Eleonora Tricarico, Marco Gatti, Anna Pecorelli, Davide Ippolito. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients. World Journal of Hepatology 2018; 10(7): 462-473 doi: 10.4254/wjh.v10.i7.462
|
| 38 |
Ben-Chen Rao, Jia-Min Lou, Wei-Jie Wang, Ang Li, Guang-Ying Cui, Zu-Jiang Yu, Zhi-Gang Ren. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2020; 19(2) doi: 10.1016/j.hbpd.2020.01.003
|
| 39 |
Chaohui Xiao, Cheng Wang, Sijie Cheng, Chengcai Lai, Peirui Zhang, Zizheng Wang, Tao Zhang, Shaogeng Zhang, Rong Liu. The significance of low levels of LINC RP1130-1 expression in human hepatocellular carcinoma. BioScience Trends 2016; 10(5) doi: 10.5582/bst.2016.01123
|